Key Takeaways
- • Direct lenders including Antares Capital, Blue Owl Capital, Carlyle and Golub Capital provided a $1.3bn loan to finance L Catterton and Altas Partners' acquisition of a majority stake in healthcare platform Fullscript, according to Bloomberg.
- • The loan priced at 400 basis points over SOFR and was issued at 96 cents on the dollar.
- • The private credit placement replaced debt commitments underwritten by a Morgan Stanley-led bank group after leveraged loan investors showed insufficient demand for a syndicated deal.
- • Morgan Stanley also provided a $230m revolving credit facility as part of the financing package.
- • The transaction shows private credit capacity absorbing large leveraged buyout financings that the broadly syndicated loan market could not clear.
Summary
Morgan Stanley reportedly placed the loan with direct lenders including Antares Capital, Blue Owl Capital, Carlyle and Golub Capital. The loan priced at 400 basis points above the Secured Overnight Financing Rate and was issued at 96 cents on the dollar. Morgan Stanley also provided a $230m revolving credit facility.
The placement followed early talks with leveraged loan investors that generated insufficient demand for a syndication in that market. The banks had committed to a maximum spread of 400 basis points and would otherwise have had to fund the acquisition under their underwriting commitments, which is why the deal was moved to direct lenders.
Fullscript announced in September that L Catterton and Altas Partners would acquire a majority stake from HGGC and Snapdragon Capital Partners. The debt placement marks the latest example of private credit funds stepping in to finance sponsor-backed buyouts that the syndicated leveraged loan market was unable to absorb at the bank-committed terms.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.